Team:HokkaidoU Japan/Safety

From 2012.igem.org

(Difference between revisions)
Line 15: Line 15:
Saftey and health of reseachers:  in the method of bioplastic polymer extraction,<br />
Saftey and health of reseachers:  in the method of bioplastic polymer extraction,<br />
the use of cloroform may have the risk of injury.  This risk can be avoided by the use of  
the use of cloroform may have the risk of injury.  This risk can be avoided by the use of  
-
gloves and eye glasses .
+
gloves and eye glasses .<br />
 +
 
 +
Public safety: Genetically engineered bacteria may accidently spread out to the environment.
 +
If the bacteria could aggerigate by them selves, it will be easier to collect them. In the future, as a measure remove bacteria from the environment, study of aggerigation protein would be useful.<br />
 +
 
Envrionmental saftey:  Cleaning and diposing of bacteria,bioproducts,wastes, are needed by special  
Envrionmental saftey:  Cleaning and diposing of bacteria,bioproducts,wastes, are needed by special  

Revision as of 02:48, 1 September 2012

1.
Would the materials used in your project and/or your final product pose
Risks to the safety and health of team members or others in the lab?
Risks to the safety and health of the general public if released by design or accident?
Risks to environmental quality if released by design or accident?
Risks to security through malicious misuse by individuals, groups or states?
Saftey and health of reseachers: in the method of bioplastic polymer extraction,
the use of cloroform may have the risk of injury. This risk can be avoided by the use of gloves and eye glasses .
Public safety: Genetically engineered bacteria may accidently spread out to the environment. If the bacteria could aggerigate by them selves, it will be easier to collect them. In the future, as a measure remove bacteria from the environment, study of aggerigation protein would be useful.
Envrionmental saftey: Cleaning and diposing of bacteria,bioproducts,wastes, are needed by special infrastructure.
2.
Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, did you document these issues in the Registry? how did you manage to handle the safety issue? How could other teams learn from your experience?
The parts we submitted this year does not have saftey risks according to professional judgment.
3.
Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?
We have “the Safety Office of Genetic Recombination in Hokkaido University”.
Our lab is equipped appropriately for the manipulation and genetic recombination of bacterial cells. Team members are instructed according to the safety training manual.
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering? ?